These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9264782)

  • 1. [Genetic therapy for hemophiliacs--therapeutic potential and technological limits].
    Michou AI; Christ M; Pavirani A; Mehtali M
    Transfus Clin Biol; 1997; 4(3):251-61. PubMed ID: 9264782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A.
    García-Martín C; Chuah MK; Van Damme A; Robinson KE; Vanzieleghem B; Saint-Remy JM; Gallardo D; Ofosu FA; Vandendriessche T; Hortelano G
    J Gene Med; 2002; 4(2):215-23. PubMed ID: 11933222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
    Miao CH; Ye X; Thompson AR
    Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut epithelial cells as targets for gene therapy of hemophilia.
    Lozier JN; Yankaskas JR; Ramsey WJ; Chen L; Berschneider H; Morgan RA
    Hum Gene Ther; 1997 Aug; 8(12):1481-90. PubMed ID: 9287148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver.
    Park F; Ohashi K; Kay MA
    Blood; 2000 Aug; 96(3):1173-6. PubMed ID: 10910939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus-mediated gene transfer for the haemophilias.
    Walsh CE; Chao H
    Haemophilia; 2002 Mar; 8 Suppl 2():60-7. PubMed ID: 11966856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
    Le Quellec S; Dane A; Enjolras N; McIntosh J; Rosales C; Negrier C; Nathwani A
    Haemophilia; 2019 Jan; 25(1):e11-e18. PubMed ID: 30520547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector.
    Balagué C; Zhou J; Dai Y; Alemany R; Josephs SF; Andreason G; Hariharan M; Sethi E; Prokopenko E; Jan HY; Lou YC; Hubert-Leslie D; Ruiz L; Zhang WW
    Blood; 2000 Feb; 95(3):820-8. PubMed ID: 10648392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
    Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
    Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated gene transfer for hemophilia.
    High KA
    Ann N Y Acad Sci; 2001 Dec; 953():64-74. PubMed ID: 11795424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems and prospects in gene therapy for hemophilia.
    Herzog RW; High KA
    Curr Opin Hematol; 1998 Sep; 5(5):321-6. PubMed ID: 9776210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
    Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM
    Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for the hemophilias.
    Walter J; High KA
    Adv Vet Med; 1997; 40():119-34. PubMed ID: 9395731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive and species-specific assay for quantification of human transgene expression levels.
    Haack A; Poller W; Schneider-Rasp S; Thalheimer P; Schmitt C; Hanfland P; Brackmann HH; Schwaab R
    Haemophilia; 1999 Sep; 5(5):334-9. PubMed ID: 10583515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilia gene therapy: From trailblazer to gamechanger.
    Evens H; Chuah MK; VandenDriessche T
    Haemophilia; 2018 May; 24 Suppl 6():50-59. PubMed ID: 29878653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for haemophilia.
    Pasi KJ
    Br J Haematol; 2001 Dec; 115(4):744-57. PubMed ID: 11843805
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.
    Chiang GG; Rubin HL; Cherington V; Wang T; Sobolewski J; McGrath CA; Gaffney A; Emami S; Sarver N; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1999 Jan; 10(1):61-76. PubMed ID: 10022531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.